Structural Activity Relationships of Indirect Sympathomimetic Agents

Indirect sympathomimetic agents play a crucial role in pharmacology by promoting the release of endogenous norepinephrine (NE). This mechanism allows these compounds to act effectively at adrenergic receptors, leading to various physiological effects. Understanding their structure-activity relationships (SAR) is essential for developing effective medications with minimal side effects.

Hydroxyamphetamine Overview

Hydroxyamphetamine acts primarily by stimulating the release of norepinephrine from adrenergic nerve terminals. Upon administration, it engages both alpha and beta receptors within the peripheral nervous system, facilitating the release of noradrenaline.

Metabolism

The metabolism of hydroxyamphetamine involves conversion by the cytochrome P450 enzyme system, specifically CYP2D6, which transforms amphetamine into 4-hydroxyamphetamine. This compound is then further metabolised by dopamine beta-hydroxylase into 4-hydroxynorephedrine, which is subsequently excreted in the urine.

Therapeutic Applications

Hydroxyamphetamine is primarily employed in ophthalmology to dilate pupils during diagnostic procedures and surgeries. Additionally, it has applications in treating narcolepsy, depressive disorders, motion sickness, and obesity.

Adverse Reactions

Potential side effects include dry mouth, agitation, sleeplessness, and anorexia. Higher doses may lead to more severe reactions such as hypertension, tachycardia, angina, and arrhythmias.

Structure-Activity Relationship

The SAR of hydroxyamphetamine is characterised by several key reactions:

1. 4-methoxybenzaldehyde and nitroethane react with a primary amine to yield benzene 1-methoxy-4-((Z)-2-nitroprop-1-enyl).
2. The combination of iron and hydrochloric acid (HCl) produces 1-(4-methoxyphenyl) propan-2-one.
3. Treatment with amide results in an unstable compound that upon HCl treatment produces 1-(4-methoxyphenyl) propan-2-amine.
4. Finally, reacting with 40% hydrobromic acid (HBr) yields hydroxyamphetamine.

Pseudoephedrine Overview

Pseudoephedrine is the (S,S) diastereoisomer of ephedrine, primarily functioning through indirect mechanisms with minimal direct activity on adrenergic receptors.

Metabolism

This compound undergoes incomplete metabolism in the liver via N-demethylation, with 55% to 75% of the administered dose excreted unchanged in urine, while the remainder is eliminated as metabolites.

Therapeutic Applications

Commonly found in over-the-counter products, pseudoephedrine is used as a nasal decongestant due to its reduced central nervous system effects compared to ephedrine.

Adverse Reactions

Adverse effects associated with pseudoephedrine include CNS stimulation, insomnia, anxiety, dizziness, and tachycardia. Rarely, it may cause mydriasis, stroke, arrhythmias, hypertension, seizures, and severe skin reactions.

Structure-Activity Relationship

Pseudoephedrine is classified as a phenethylamine and ephedrine diastereomer. Its sympathomimetic properties arise from its ability to release norepinephrine into presynaptic vesicles, activating alpha-adrenergic receptors. This action leads to vasoconstriction, effectively alleviating nasal and sinus congestion.

Propylhexedrine Overview

Propylhexedrine, an amphetamine analogue, features a cyclohexane ring in place of the aromatic ring found in other sympathomimetics. It primarily acts as a nasal decongestant.

Mechanism of Action

The drug induces vasoconstriction and exhibits decongestant effects on nasal membranes while having a lesser impact on the central nervous system.

Metabolism

Propylhexedrine is metabolised into several compounds, including norpropylhexedrine, cyclohexylacetoxime, and both cis and trans-4-hydroxypropylhexedrine.

Therapeutic Applications

Its main application is as a local vasoconstrictor for treating nasal congestion resulting from colds, allergic rhinitis, or sinusitis.

Adverse Reactions

Common side effects include increased nasal discharge, burning, stinging, and sneezing.

Structure-Activity Relationship

Propylhexedrine, based on propylamine, exhibits sympathomimetic properties by binding to and activating alpha-adrenergic receptors in the respiratory tract mucosa. This mimics norepinephrine and epinephrine, leading to vasoconstriction and reduced inflammation in the mucous membranes, thus relieving nasal congestion.